#100DaysMission
📢 Three stories, one newsletter!

It's been a busy few weeks for the #100DaysMission. We've put three updates we wanted you to hear all in one place.

Read more (plus how to get involved) in the newsletter 👇
mailchi.mp/ippsecretar...
October 15, 2026 at 9:09 AM
Dr Lisa McDonald, Global Health Security Fund, on the problem behind the BioPREVAIL × @cepi.net Biosecurity Innovation Challenge.

🔗 Startups, labs, companies and research groups can apply by 31 October: bioprevail.org/apply

#Biosecurity #Opportunity #Startup #PandemicPreparedness #100DaysMission
October 1, 2026 at 12:59 PM
World leaders meet at the UN this week to lock in pandemic pledges. The real news: an AI 'factory' quietly built to design vaccines in days, not months. Here's what it can (and can't) do yet. #PandemicPreparedness #AI #GlobalHealth #100DaysMission

artificialscience.org/2026/09/ai-f...
The World Just Built an AI Factory for the Next Pandemic — Artificial Science
As world leaders gather at the UN for a High-Level Meeting on pandemics, a new AI-powered global infrastructure (the Pandemic Preparedness Engine and Global Pathogen Analysis Platform) is quietly bein...
artificialscience.org
September 24, 2026 at 5:35 AM
@dndi.org's Rachel Cohen: ''This is a fragile moment - we know the geopolitical reality is devastating funding cuts. We have hope at @dndi.org on research into antivirals - there’s an enormous appetite for collective and multisectoral action.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
@medicinespatentpool.org's Charles Gore comments: ''We need to have licenses in place and then triggered before a pandemic. Trying to put things in place interpandemic times to move as quickly as possible''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
''Brazil's COVID response was based on existing institutions which requires sustained investment. A new biotech industry incl. fill & finish for vaccines - responds to Brazil's needs & can be used regionally, capacity allowing.'' - Priscila Ferraz Soares

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
Malcolm Sowah: ''It's important that we maintain capabilities between crises. This means effective surveillance, clinical trial networks and regulatory readiness.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
''Industry want to be a part of the solution. Contracts need to be compatible with business requirements - legal and commercial obligations - happening right now with BDBV.'' - James Anderson, IFPMA

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
@ippsecretariat.org's Sheila Mburu (contd): ''Regulatory harmonisation in an emergency context is also key. At IPPS, we are working with @path.org to landscape the harmonisation approach across regulatory issues.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
On BDBV, Sheila Mburu reflects on diagnostics availability: ''At Day 100 we still don’t have a true point-of-care test. This is essential for communities that don’t have access to centralised testing.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
@ippsecretariat.org's Sheila Mburu reflects on the ongoing BDBV outbreak: ''In this ongoing outbreak, we are flying blind, need to detect early in order to respond...having sample access and finalising the PABS annex is key to this''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
Dr Priscila Ferraz Soares @fiocruz.bsky.social highlights: ''Brazil has launched new industrial policy focused on reducing external dependence, increasing mass production & new legislation on the health complex as a national asset for health security & innovation.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
Closing the event, Dr Victor Dzau highlighted some final considerations:

1/ Monitoring and evaluation is crucial: we have the #100DaysMission Scorecard, which will continue until at least 2028 led by @impactglobalhealth.bsky.social following IPPS' sunset in early 2027.
September 22, 2026 at 12:30 PM
IFPMA's James Anderson on industry perspectives: ''Pandemic preparedness is insurance for the world. We all need it. Industry have supported the #100DaysMission since the beginning - expertise, products, science - to help the world prepare and respond to outbreaks''

#UNGA81
September 22, 2026 at 12:30 PM
Sowah continues: ''We also launched a Biological Security Strategy which complements the PPR strategy. We also have a cross-govt Board on 100DM. The 100 day goal can’t sit separately from national efforts on surveillance and manufacturing efforts”

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
Our second panel session is on ''Delivering the 100 Days Mission: Preparedness in Practice''

Perspectives on embedding the 100 day goal in the strategies, policies & capabilities to enable rapid response w/ inputs from Fiocruz, IFPMA and the UK Mission to the UN.

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
Malcolm Sowah of the UK Mission to the UN on UK progress: ''UK just launched PPR strategy which is the centre of this ambition to take rapid & coordinated action. It draws on COVID-19 and simulation exercise on PPR. Moving from preparing from one disease to many.''

#100DaysMission #UNGA81
September 22, 2026 at 12:30 PM
@cepi.net's Dr Richard Hatchett on progress: ''The #100DaysMission is an aspiration, but BDBV is a perfect case to tell us how we’ve progressed towards it. We’re almost at Phase 1 trials. This is an example of Disease X in practice. 100DM is a multi year investment to get there.''

#UNGA81
September 22, 2026 at 12:30 PM
Thank you for following along with today's event as part of @devex.com Impact House @ #UNGA81, and thank you to our host Rumbie Chakamba.

You can sign up to receive a recording of the event via Devex here: dvx.cm/bgxtab

#100DaysMission
Devex Impact House @ UNGA 81
From Sept. 21 to 24, as world leaders converge in New York City for the U.N. General Assembly and Climate Week, Devex will open its doors to host bold, news-driven conversations on the future of global development. Across three days of programming, Devex journalists will lead live news interviews, curated roundtables, and high-level partner events with the leaders you’ve heard of and those you should.
dvx.cm
September 22, 2026 at 12:30 PM
🔴 Devex Impact House @ #UNGA81 is underway: the #100DaysMission session has opened with remarks from IPPS STEG Co-Chair Dr. Victor Dzau.

Follow this thread for updates 🧵

On-demand content: pages.devex.com/devex-at-un...

#100DaysMission #PandemicPreparedness
September 21, 2026 at 12:14 PM
Our first panel session is on 'Delivering the #100DaysMission: Building the Enabling Ecosystem', with insights from @dndi.org, @cepi.net and @ippsecretariat.org.

What are the capabilities, partnerships and investments needed to accelerate medical countermeasure readiness?

#UNGA81
September 21, 2026 at 12:36 PM
@dndi.org's Rachel Cohen highlights a key gap: ''As set out by WHO & Africa CDC in The Lancet, although we have the beginnings of an ecosystem for vaccines, we have no ecosystem for therapeutics or for diagnostics''

#100DaysMission #UNGA81
September 21, 2026 at 12:36 PM
How can defense and public health sectors collaborate to achieve the #100DaysMission?

A new report by @pandemiccenter.bsky.social, @cepi.net & @randeurope.org identifies key areas where cross-sector cooperation can make the biggest impact.

pandemics.sph.brown.edu/news/2026-08...
Report Release: Realising the 100 Days Mission
Accelerating Defence and Health Capabilities for Medical Countermeasures Readiness
pandemics.sph.brown.edu
August 24, 2026 at 4:00 PM
A new report from @pandemiccenter.bsky.social, @cepi.net, and @rand.org details key areas for defense and health investment to advance #100DaysMission and outlines recommendations for cross-sector collaboration to deliver faster pandemic preparedness and response.

static.cepi.net/downloads/20...
August 17, 2026 at 4:26 PM
Happy to announce our initial work on validation of Pseudovirus neutralization assay for Nipah vaccine evaluation. The work was funded by CEPI.

#NipahVirus
#100daysMission
#CEPI
Development and Validation of a Standardized Pseudotyped Virus-Based Neutralization Assay for Assessment of Anti-Nipah Virus Neutralizing Activity in Candidate Nipah Vaccines - PubMed
<span><b>Background:</b> An effective vaccine against Nipah virus (NiV) is crucial due to its high fatality rate and recurrent outbreaks in South and Southeast Asia. Vaccine development is challenged ...
pubmed.ncbi.nlm.nih.gov
October 21, 2025 at 5:26 PM